ImageneBio Inc (IMA) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for ImageneBio Inc in 2026. The next earnings report is expected on November 11, 2026.
Next earnings date
11 Nov 2026
In 82 days
EPS estimate
-0.72
Revenue estimate
0
Past earnings
Latest earnings analysis
ImageneBio Inc beat consensus estimates in its latest earnings report, with EPS of $-0.63 versus an estimate of $-0.9767 and revenue met expectations at $0. In the prior report EPS missed expectations while revenue met expectations.
No dividend history available.
Clinical-stage biotechnology company developing differentiated therapies for immunological/autoimmune & inflammatory (I&I) diseases, notably non‑depleting anti‑OX40 monoclonal antibody IMG‑007 in Phase 2b for atopic dermatitis
ImageneBio Inc (IMA) is scheduled to report earnings on November 11, 2026.
ImageneBio Inc (IMA) last reported earnings on August 5, 2026.
ImageneBio Inc (IMA) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.